A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat. 2016;48(3):1120-1129. Published online 2016 Feb 12 DOI: https://doi.org/10.4143/crt.2015.436
Citations to this article as recorded by 
Therapeutic Drug Monitoring of Imatinib and N‐Desmethyl Imatinib in Chronic Myeloid Leukemia Patients Using LC‐MS/MS in a Cohort Study
Xiaoxing Huang, Yiwei Liu, Jie Chen, Heng Zheng, Yufeng Ding, Zheng He
The Journal of Clinical Pharmacology.2023; 63(12): 1438. CrossRef
Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs
Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Ahmet Emre Eşkazan
Blood Advances.2021; 5(17): 3344. CrossRef
Challenges in Chronic Myeloid Leukemia Management in South America
Katia B. Pagnano, Ana Ines Varela, Carolina Pavlovsky, Israel Bendit, Vaneuza A. M. Funke, Virginia Abello Polo
Current Hematologic Malignancy Reports.2021; 16(5): 440. CrossRef
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Fengxu Wu, Yuquan Zhou, Langhui Li, Xianhuan Shen, Ganying Chen, Xiaoqing Wang, Xianyang Liang, Mengyuan Tan, Zunnan Huang
Frontiers in Chemistry.2020;[Epub] CrossRef
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
Maria Gemelli, Elena Maria Elli, Chiara Elena, Alessandra Iurlo, Tamara Intermesoli, Margherita Maffioli, Ester Pungolino, Maria Cristina Carraro, Mariella D'Adda, Francesca Lunghi, Michela Anghileri, Nicola Polverelli, Marianna Rossi, Mattia Bacciocchi,
BLOOD RESEARCH.2020; 55(3): 139. CrossRef
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
Iman Abou Dalle, Hagop Kantarjian, Jan Burger, Zeev Estrov, Maro Ohanian, Srdan Verstovsek, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia‐Manero, Elias Jabbour, Jorge Cortes
Cancer Medicine.2019; 8(15): 6559. CrossRef
[ARTICLE WITHDRAWN] Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.2018; 26(2): 297. CrossRef
LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
Xiangyu Zhou, Ping Yuan, Qi Liu, Zhiqiang Liu
Biomolecules & Therapeutics.2017; 25(5): 490. CrossRef